Matches in Wikidata for { <http://www.wikidata.org/entity/Q66064364> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q66064364 description "clinical trial" @default.
- Q66064364 description "ensayu clínicu" @default.
- Q66064364 description "klinisch onderzoek" @default.
- Q66064364 description "клінічне випробування" @default.
- Q66064364 name "A Study Of SIBP-01 Or CN-Trastuzumab Plus Docetaxel And Carboplatin In HER2 Positive Breast Cancer" @default.
- Q66064364 name "A Study Of SIBP-01 Or CN-Trastuzumab Plus Docetaxel And Carboplatin In HER2 Positive Breast Cancer" @default.
- Q66064364 type Item @default.
- Q66064364 label "A Study Of SIBP-01 Or CN-Trastuzumab Plus Docetaxel And Carboplatin In HER2 Positive Breast Cancer" @default.
- Q66064364 label "A Study Of SIBP-01 Or CN-Trastuzumab Plus Docetaxel And Carboplatin In HER2 Positive Breast Cancer" @default.
- Q66064364 prefLabel "A Study Of SIBP-01 Or CN-Trastuzumab Plus Docetaxel And Carboplatin In HER2 Positive Breast Cancer" @default.
- Q66064364 prefLabel "A Study Of SIBP-01 Or CN-Trastuzumab Plus Docetaxel And Carboplatin In HER2 Positive Breast Cancer" @default.
- Q66064364 P1132 Q66064364-09A05619-8C40-42E5-95BD-585DDF67605A @default.
- Q66064364 P1476 Q66064364-FCB9CDAD-5B34-4602-A464-3AAC4260F23B @default.
- Q66064364 P2899 Q66064364-C65E4B98-C91E-4315-954C-5B24625410B0 @default.
- Q66064364 P3098 Q66064364-66E4FCA0-2A0C-4B33-A8D2-B2B76CA8C809 @default.
- Q66064364 P31 Q66064364-7C6FCEC7-7E95-4DEB-9238-D0922717544D @default.
- Q66064364 P4135 Q66064364-6067C385-0EA9-448C-A106-0985873117CB @default.
- Q66064364 P4844 Q66064364-85BE9F05-A9DD-4F5C-8FE9-97856514618D @default.
- Q66064364 P580 Q66064364-23BC7517-108E-4800-9E18-C19612CAA7F9 @default.
- Q66064364 P582 Q66064364-40EA917F-DC4E-4ED2-871E-117DA28A4C36 @default.
- Q66064364 P6099 Q66064364-BAF35D84-124E-457C-9AFB-0ED5B6F66E96 @default.
- Q66064364 P6153 Q66064364-E62ED9F3-4E1F-49A2-9164-B4BA56520496 @default.
- Q66064364 P767 Q66064364-D2055700-AFAD-4B5B-AFBA-357E785944CE @default.
- Q66064364 P8363 Q66064364-7B0C05B3-0F15-46A1-8BBE-1B8606B1E66A @default.
- Q66064364 P1132 "+580" @default.
- Q66064364 P1476 "A Phase III, Randomized, Single-blind Study Comparing the Efficacy, Safety, and Immunogenicity of SIBP-01 and CN-Trastuzumab Combination With Docetaxel and Carboplatin in Patients With Early or Locally Advanced Her2 Positive Breast Cancer" @default.
- Q66064364 P2899 "+18" @default.
- Q66064364 P3098 "NCT03989037" @default.
- Q66064364 P31 Q30612 @default.
- Q66064364 P4135 "+75" @default.
- Q66064364 P4844 Q415588 @default.
- Q66064364 P580 "2019-06-30T00:00:00Z" @default.
- Q66064364 P582 "2021-05-28T00:00:00Z" @default.
- Q66064364 P6099 Q42824827 @default.
- Q66064364 P6153 Q495015 @default.
- Q66064364 P767 Q495015 @default.
- Q66064364 P8363 Q78089383 @default.